Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência.

August 18, 2020August 18, 2020

University Given $3.9M to Advance Potential COPD Therapy to Clinical Testing

News

Researchers at Washington University School of Medicine in St. Louis have been awarded $3.9 million in funding to continue developing a treatment candidate that reduces mucus production and inflammation ... Read more

August 11, 2020August 11, 2020

Healthy Diet Significantly Lowers COPD Risk, Review Study Finds

News

Adhering to a healthy diet — be it a Mediterranean diet, a prudent diet, or a diet supported by health associations — significantly lowers the risk of chronic obstructive ... Read more

June 2, 2020June 2, 2020

COPD, Smoking Increase Death Risk in COVID-19 Patients, Study Says

News

Smokers and people with chronic obstructive pulmonary disease (COPD) are more likely to develop severe complications and die from COVID-19 infections than infected patients who do not smoke or have ... Read more

May 7, 2020May 7, 2020

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

News

People with chronic obstructive pulmonary disease (COPD) have three unusual stem cell subsets in their lungs that, together, seem to contribute to the inflammation, tissue scarring, and excessive mucus ... Read more

April 16, 2020April 16, 2020

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

News

MP1032, an anti-inflammatory molecule developed by MetrioPharm, inhibits the formation of 3-nitrotyrosine — a biomarker of nitrogen reactive species — induced by cigarette smoke in the air sacs of ... Read more

March 26, 2020March 26, 2020

COPD Patients Vulnerable to Severe COVID-19 Infections, Study Finds

News

People with chronic obstructive pulmonary disease (COPD) are among the most vulnerable to COVID-19 infections, being even more likely to develop severe disease or to be admitted to intensive ... Read more

August 18, 2016August 18, 2016

Airway Hyperreactivity Test May Identify COPD Patients with Asthma Overlap

News

Patients with chronic obstructive pulmonary disease (COPD) who exhibit asthma symptoms may have poorer outcomes than other COPD patients, according to a study developed by researchers at St Paul’s Hospital in Vancouver, ... Read more

July 21, 2016July 21, 2016

Opioid Use in Older COPD Patients Can Worsen Prognosis

News

Treating older adults with chronic obstructive pulmonary disease (COPD) with opioids may not be the best idea. Researchers at St. Michael’s Hospital, in Toronto, Canada, have shown that new ... Read more

June 21, 2016June 21, 2016

Triple Combination Therapy Shows Promise in COPD; Superior to Symbicort/Turbohaler Therapies

News

GlaxoSmithKline and Innoviva announced positive data from the Phase 3 FULFIL clinical trial evaluating their investigational triple combination therapy with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/IV) in patients with chronic obstructive pulmonary disease (COPD). FULFIL ... Read more

Pin It on Pinterest